The atypical chemokine receptor D6 contributes to the development of experimental colitis

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 5032-5040

  Bordon, Yvonne ^a   Hansell, Chris A H ^a   Sester, David P ^a,b   Clarke, Mairi ^a   Mowat, Allan McI ^a   Nibbs, Robert J B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR D6; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 17; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR CCR10; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GAMMA DELTA T LYMPHOCYTE; IN VIVO STUDY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; SYMPTOMATOLOGY; T LYMPHOCYTE; UPREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; SECRETION;

ANIMALS; COLITIS; DEXTRAN SULFATE; INTERLEUKIN-17; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, CCR10; T-LYMPHOCYTES; UP-REGULATION;

EID: 65249094930     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802802     Document Type: Article

References (54)

1. Mackay, C. R. 2001. Chemokines: immunology's high impact factors. Nat. Immunol. 2: 95-101.
2. Murphy, P. M., M. Baggiolini, I. F. Charo, C. A. Hebert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power. 2000. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176.
3. Nibbs, R., G. Graham, and A. Rot. 2003. Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6. Semin. Immunol. 15: 287-294.
4. Fra, A. M., M. Locati, K. Otero, M. Sironi, P. Signorelli, M. L. Massardi, M. Gobbi, A. Vecchi, S. Sozzani, and A. Mantovani. 2003. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J. Immunol. 170: 2279-2282.
5. Bonecchi, R., M. Locati, E. Galliera, M. Vulcano, M. Sironi, A. M. Fra, M. Gobbi, A. Vecchi, S. Sozzani, B. Haribabu, et al. 2004. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J. Immunol. 172: 4972-4976. (Pubitemid 38456423)
6. Jamieson, T., D. N. Cook, R. J. Nibbs, A. Rot, C. Nixon, P. McLean, A. Alcami, S. A. Lira, M. Wiekowski, and G. J. Graham. 2005. The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 6: 403-411. (Pubitemid 41716781)
7. Martinez de la Torre, Y., M. Locati, C. Buracchi, J. Dupor, D. N. Cook, R. Bonecchi, M. Nebuloni, D. Rukavina, L. Vago, A. Vecchi, et al. 2005. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur. J. Immunol. 35: 1342-1346. (Pubitemid 40691415)
8. Whitehead, G. S., T. Wang, L. M. Degraff, J. W. Card, S. A. Lira, G. J. Graham, and D. N. Cook. 2007. The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am. J. Respir. Crit. Care Med. 175: 243-249.
9. Martinez de la Torre, Y., C. Buracchi, E. M. Borroni, J. Dupor, R. Bonecchi, M. Nebuloni, F. Pasqualini, A. Doni, E. Lauri, C. Agostinis, et al. 2007. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc. Natl. Acad. Sci. USA 104: 2319-2324.
10. Nibbs, R. J., D. S. Gilchrist, V. King, A. Ferra, S. Forrow, K. D. Hunter, and G. J. Graham. 2007. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J. Clin. Invest. 117: 1884-1892.
11. Nibbs, R. J., E. Kriehuber, P. D. Ponath, D. Parent, S. Qin, J. D. Campbell, A. Henderson, D. Kerjaschki, D. Maurer, G. J. Graham, and A. Rot. 2001. The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am. J. Pathol. 158: 867-877.
12. Gijsbers, K., K. Geboes, and J. Van Damme. 2006. Chemokines in gastrointestinal disorders. Curr. Drug Targets 7: 47-64.
13. Reinecker, H. C., E. Y. Loh, D. J. Ringler, A. Mehta, J. L. Rombeau, and R. P. MacDermott. 1995. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 108: 40-50.
14. Grimm, M. C., S. K. Elsbury, P. Pavli, and W. F. Doe. 1996. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J. Leukocyte Biol. 59: 804-812.
15. Wedemeyer, J., A. Lorentz, M. Goke, P. N. Meier, P. Flemming, C. A. Dahinden, M. P. Manns, and S. C. Bischoff. 1999. Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa. Gut 44: 629-635. (Pubitemid 29195909)
16. + lymphocyte-associated Th2-type immune response in the intestine. J. Immunol. 164: 6303-6312.
17. Uyttenhove, C., and J. Van Snick. 2006. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur. J. Immunol. 36: 2868-2874. (Pubitemid 44782560)
18. Okayasu, I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702. (Pubitemid 20069706)
19. Yang, S. K., M. S. Choi, O. H. Kim, S. J. Myung, H. Y. Jung, W. S. Hong, J. H. Kim, and Y. I. Min. 2002. The increased expression of an array of C-X-C and C-C chemokines in the colonic mucosa of patients with ulcerative colitis: regulation by corticosteroids. Am. J. Gastroenterol. 97: 126-132.
20. Banks, C., A. Bateman, R. Payne, P. Johnson, and N. Sheron. 2003. Chemokine expression in IBD: mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J. Pathol. 199: 28-35. (Pubitemid 36054726)
21. McCormack, G., D. Moriarty, D. P. O'Donoghue, P. A. McCormick, K. Sheahan, and A. W. Baird. 2001. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm. Res. 50: 491-495. (Pubitemid 32999710)
22. Tokuyama, H., S. Ueha, M. Kurachi, K. Matsushima, F. Moriyasu, R. S. Blumberg, and K. Kakimi. 2005. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis. Int. Immunol. 17: 1023-1034. (Pubitemid 41158385)
23. Egger, B., M. Bajaj-Elliott, T. T. MacDonald, R. Inglin, V. E. Eysselein, and M. W. Buchler. 2000. Characterization of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62: 240-248.
24. Ito, R., M. Shin-Ya, T. Kishida, A. Urano, R. Takada, J. Sakagami, J. Imanishi, M. Kita, Y. Ueda, Y. Iwakura, et al. 2006. Interferon-γ is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol. 146: 330-338. (Pubitemid 44581349)
25. Ogawa, A., A. Andoh, Y. Araki, T. Bamba, and Y. Fujiyama. 2004. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110: 55-62. (Pubitemid 38177420)
26. Yang, X. O., S. H. Chang, H. Park, R. Nurieva, B. Shah, L. Acero, Y. H. Wang, K. S. Schluns, R. R. Broaddus, Z. Zhu, and C. Dong. 2008. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205: 1063-1075.
27. Di Liberto, D., M. Locati, N. Caccamo, A. Vecchi, S. Meraviglia, A. Salerno, G. Sireci, M. Nebuloni, N. Caceres, P. J. Cardona, et al. 2008. Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J. Exp. Med. 205: 2075-2084.
28. Cobrin, G. M., and M. T. Abreu. 2005. Defects in mucosal immunity leading to Crohn's disease. Immunol. Rev. 206: 277-295. (Pubitemid 41105176)
29. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241. (Pubitemid 38962578)
30. Araki, A., T. Kanai, T. Ishikura, S. Makita, K. Uraushihara, R. Iiyama, T. Totsuka, K. Takeda, S. Akira, and M. Watanabe. 2005. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40: 16-23. (Pubitemid 40796328)
31. Fukata, M., K. S. Michelsen, R. Eri, L. S. Thomas, B. Hu, K. Lukasek, C. C. Nast, J. Lechago, R. Xu, Y. Naiki, et al. 2005. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. 288: G1055-G1065. (Pubitemid 40563149)
32. Cario, E. L., G. U. Gerken, and D. A. Podolsky. 2007. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132: 1359-1374.
33. Naito, Y., T. Takagi, O. Handa, T. Ishikawa, S. Nakagawa, T. Yamaguchi, N. Yoshida, M. Minami, M. Kita, J. Imanishi, and T. Yoshikawa. 2003. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-α deficient mice. J. Gastroenterol. Hepatol. 18: 560-569. (Pubitemid 36645291)
34. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527. (Pubitemid 32835046)
35. McKenzie, B. S., R. A. Kastelein, and D. J. Cua. 2006. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27: 17-23.
36. Kinugasa, T., T. Sakaguchi, X. Gu, and H. C. Reinecker. 2000. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118: 1001-1011. (Pubitemid 30346975)
37. Kanda, N., S. Koike, and S. Watanabe. 2005. IL-17 suppresses TNF-α-induced CCL27 production through induction of COX-2 in human keratinocytes. J. Allergy Clin. Immunol. 116: 1144-1150. (Pubitemid 41571801)
38. Morteau, O., S. G. Morham, R. Sellon, L. A. Dieleman, R. Langenbach, O. Smithies, and R. B. Sartor. 2000. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J. Clin. Invest. 105: 469-478. (Pubitemid 30127247)
39. Chen, Y., K. Chou, E. Fuchs, W. L. Havran, and R. Boismenu. 2002. Protection of the intestinal mucosa by intraepithelial γδ T cells. Proc. Natl. Acad. Sci. USA 99: 14338-14343. (Pubitemid 35257673)
40. Jameson, J., K. Ugarte, N. Chen, P. Yachi, E. Fuchs, R. Boismenu, and W. L. Havran. 2002. A role for skin γδ T cells in wound repair. Science 296: 747-749. (Pubitemid 34442005)
41. Yang, H., P. A. Antony, B. E. Wildhaber, and D. H. Teitelbaum. 2004. Intestinal intraepithelial lymphocyte γδ-T cell-derived keratinocyte growth factor modulates epithelial growth in the mouse. J. Immunol. 172: 4151-4158. (Pubitemid 38375227)
42. Boismenu, R., and W. L. Havran. 1994. Modulation of epithelial cell growth by intraepithelial γδ T cells. Science 266: 1253-1255. (Pubitemid 24371285)
43. Hayday, A., and R. Tigelaar. 2003. Immunoregulation in the tissues by γδ T cells. Nat. Rev. Immunol. 3: 233-242.
44. Lockhart, E., A. M. Green, and J. L. Flynn. 2006. IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177: 4662-4669. (Pubitemid 44469799)
45. + γδ T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178: 4466-4472.
46. Umemura, M., A. Yahagi, S. Hamada, M. D. Begum, H. Watanabe, K. Kawakami, T. Suda, K. Sudo, S. Nakae, Y. Iwakura, and G. Matsuzaki. 2007. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178: 3786-3796. (Pubitemid 46417647)
47. Roark, C. L., P. L. Simonian, A. P. Fontenot, W. K. Born, and R. L. O'Brien. 2008. γδ T cells: an important source of IL-17. Curr. Opin. Immunol. 20: 353-357.
48. + γδ cells as fetal thymus-derived naturally occurring IL-17 producers. J. Immunol. 181: 5940-5947.
49. McKimmie, C. S., A. R. Fraser, C. Hansell, L. Gutierrez, S. Philipsen, L. Connell, A. Rot, M. Kurowska-Stolarska, P. Carreno, M. Pruenster, et al. 2008. Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J. Immunol. 181: 8171-8181.
50. Kin, N. W., D. M. Crawford, J. Liu, T. W. Behrens, and J. F. Kearney. 2008. DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae. J. Immunol. 180: 6663-6674.
51. Mantovani, A., R. Bonecchi, and M. Locati. 2006. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat. Rev. Immunol. 6: 907-918. (Pubitemid 44851733)
52. Penido, C., A. Vieira-de-Abreu, M. T. Bozza, H. C. Castro-Faria-Neto, and P. T. Bozza. 2003. Role of monocyte chemotactic protein-1/CC chemokine ligand 2 on γδ T lymphocyte trafficking during inflammation induced by lipopolysaccharide or Mycobacterium bovis bacille Calmette-Guerin. J. Immunol. 171: 6788-6794. (Pubitemid 37532113)
53. Roth, S. J., T. G. Diacovo, M. B. Brenner, J. P. Rosat, J. Buccola, C. T. Morita, and T. A. Springer. 1998. Transendothelial chemotaxis of human α/β and γ/δ T lymphocytes to chemokines. Eur. J. Immunol. 28: 104-113. (Pubitemid 28048281)
54. Glatzel, A., D. Wesch, F. Schiemann, E. Brandt, O. Janssen, and D. Kabelitz. 2002. Patterns of chemokine receptor expression on peripheral blood γδ T lymphocytes: strong expression of CCR5 is a selective feature of Vδ2/Vγ9 γδ T cells. J. Immunol. 168: 4920-4929. (Pubitemid 34498305)